Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study

INTRODUCTION: Autologous stem cell transplantation (ASCT) is the standard treatment for younger patients with newly diagnosed multiple myeloma (MM). However, due to restrictive exclusion criteria, more than half of eligible patients are usually excluded from transplant studies. METHODS: This retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Song-Yau, Holzhey, Tanja, Heyn, Simone, Zehrfeld, Thomas, Fricke, Susann, Hoffmann, Franz Albert, Becker, Cornelia, Braunert, Leanthe, Edelmann, Thomas, Paulenz, Inessa, Hitzschke, Marcus, Flade, Franziska, Schwarzer, Andreas, Fenchel, Klaus, Franke, Georg-Nikolaus, Vucinic, Vladan, Jentzsch, Madlen, Schwind, Sebastian, Hell, Saskia, Backhaus, Donata, Lange, Thoralf, Niederwieser, Dietger, Scholz, Markus, Platzbecker, Uwe, Pönisch, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314844/
https://www.ncbi.nlm.nih.gov/pubmed/35987926
http://dx.doi.org/10.1007/s00432-022-04184-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314844/
https://www.ncbi.nlm.nih.gov/pubmed/35987926
http://dx.doi.org/10.1007/s00432-022-04184-x

Ejemplares similares